JPRN-UMIN000009999
Completed
未知
Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agent - Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients
Department of Urology, University of the Ryukyus0 sites50 target enrollmentFebruary 12, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Urology, University of the Ryukyus
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. obvious polyuria patients 2\. patients with cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I/II Study of Combination Therapy of Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin in Patients with Unresectable and/or Recurrent Advanced Gastric Cancer Step 2: low dose cisplatin given twice a week + S-1unresectable or recurrent gastric cancerJPRN-C000000282Japanese Foundation for Multidisciplinary Treatment of Cancer52
Recruiting
Phase 1
Fuzheng huayu tablets against renal fibrosis in primary glomerulonephritis (CKD stage 3): a randomized, double-blind, placebo-controlled, multicenter clinical trialPrimary glomerulonephritis (CKD Stage 3)ITMCTR2100004925Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Active, not recruiting
Phase 1
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.EUCTR2006-003658-47-FRPierre Fabre Médicament - IRPF180
Not yet recruiting
Not Applicable
A feasibility study of combination with oral fluoropyrimidine, oxaliplatin and trastuzumab for HER2-positive advanced or recurrent gastric cancerHER2-positive unresectable advanced gastric cancerJPRN-UMIN000021554agoya University Hospital20
Recruiting
Phase 4
Does giving higher dose of folic acid improve intolerance associated with methotrexate in patients of Rheumatoid arthritisHealth Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2023/04/051346PGIMER, Chandigarh